Literature DB >> 10396189

Filtration procedures supplemented with mitomycin C in the management of childhood glaucoma.

A Azuara-Blanco1, R P Wilson, G L Spaeth, C M Schmidt, J J Augsburger.   

Abstract

AIMS: To evaluate the outcome of filtering procedures supplemented with mitomycin C in children with glaucoma.
METHODS: All patients aged 17 or younger with glaucoma who underwent filtering surgery supplemented with mitomycin C at a tertiary care centre (n = 21) during a 5 year interval (1992 and 1996) were included. One eye for each patient was entered into the analysis. The postoperative intraocular pressure (IOP), use of antiglaucoma medications, clinical stability of glaucoma, complications, and visual acuity were retrospectively evaluated. Kaplan-Meier survival curves were used to estimate the probability of success.
RESULTS: At the time of surgery mean age was 5.7 (SD 5.0) years. The most common diagnoses were trabeculodysgenesis (n = 6) and aphakic glaucoma (n = 8). Mean IOP before surgery was 35.7 (10.5) mm Hg. Average length of follow up was 18.6 (14.7) months. The probability of having IOP less than 21 mm Hg with no antiglaucoma medications and with clinically stable glaucoma 1 year after surgery was 76.9% in phakic eyes (n = 13) and 0% in aphakic eyes (n = 8). A phakic patient with Sturge-Weber's syndrome had choroidal effusion after surgery that resolved spontaneously. In the aphakic group one patient had retinal detachment and another developed an encapsulated bleb. Visual acuity deteriorated in one patient.
CONCLUSION: A guarded filtration procedure with mitomycin C is relatively successful in phakic children with glaucoma, but unsuccessful in aphakic ones.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10396189      PMCID: PMC1722934          DOI: 10.1136/bjo.83.2.151

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  34 in total

1.  Reversible optic disk cupping and visual field improvement in adults with glaucoma.

Authors:  L J Katz; G L Spaeth; L B Cantor; E M Poryzees; W C Steinmann
Journal:  Am J Ophthalmol       Date:  1989-05-15       Impact factor: 5.258

2.  Surgery of congenital cataract.

Authors:  P A Chandler
Journal:  Am J Ophthalmol       Date:  1968-05       Impact factor: 5.258

3.  Results of trabeculectomy with 0.3 mg/ml mitomycin C titrating exposure times based on risk factors for failure.

Authors:  R T Stone; L W Herndon; R R Allingham; M B Shields
Journal:  J Glaucoma       Date:  1998-02       Impact factor: 2.503

4.  Filtering surgery in children: barriers to success.

Authors:  G R Beauchamp; M M Parks
Journal:  Ophthalmology       Date:  1979-01       Impact factor: 12.079

5.  Trabeculectomy in young patients.

Authors:  M G Gressel; D K Heuer; R K Parrish
Journal:  Ophthalmology       Date:  1984-10       Impact factor: 12.079

6.  Reversal of glaucomatous cupping in adults.

Authors:  J E Pederson; J Herschler
Journal:  Arch Ophthalmol       Date:  1982-03

7.  Childhood glaucoma: results with trabeculotomy and study of reversible cupping.

Authors:  H A Quigley
Journal:  Ophthalmology       Date:  1982-03       Impact factor: 12.079

8.  Trabeculotomy compared to goniotomy for glaucoma in children.

Authors:  D R Anderson
Journal:  Ophthalmology       Date:  1983-07       Impact factor: 12.079

9.  Montgomery lecture. Goniotomy in the treatment of isolated trabeculodysgenesis (primary congenital [infantile] developmental glaucoma).

Authors:  R N Shaffer; H D Hoskins
Journal:  Trans Ophthalmol Soc U K       Date:  1983

10.  Incidence of chronic glaucoma, retinal detachment and secondary membrane surgery in pediatric aphakic patients.

Authors:  G A Chrousos; M M Parks; J F O'Neill
Journal:  Ophthalmology       Date:  1984-10       Impact factor: 12.079

View more
  9 in total

1.  Treatment results in aphakic patients with glaucoma following congenital cataract surgery.

Authors:  Mine Baris; Elif Demirkilinc Biler; Suzan Guven Yilmaz; Halil Ates; Onder Uretmen; Suheyla Kose
Journal:  Int Ophthalmol       Date:  2017-11-30       Impact factor: 2.031

2.  Augmented trabeculectomy in paediatric glaucoma.

Authors:  R Ehrlich; M Snir; M Lusky; D Weinberger; R Friling; D D Gaton
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

Review 3.  Childhood glaucoma surgery in the 21st century.

Authors:  M Papadopoulos; B Edmunds; C Fenerty; P T Khaw
Journal:  Eye (Lond)       Date:  2014-06-13       Impact factor: 3.775

4.  Surgical results of trabeculectomy and Ahmed valve implantation following a previous failed trabeculectomy in primary congenital glaucoma patients.

Authors:  Naeun Lee; Kyoung Tak Ma; Hyoung Won Bae; Samin Hong; Gong Je Seong; Young Jae Hong; Chan Yun Kim
Journal:  Korean J Ophthalmol       Date:  2015-03-17

Review 5.  Management of Childhood Glaucoma Following Cataract Surgery.

Authors:  Anne-Sophie Simons; Ingele Casteels; John Grigg; Ingeborg Stalmans; Evelien Vandewalle; Sophie Lemmens
Journal:  J Clin Med       Date:  2022-02-17       Impact factor: 4.241

6.  Current surgical options for the management of pediatric glaucoma.

Authors:  Jose Morales; Sami Al Shahwan; Sami Al Odhayb; Ibrahim Al Jadaan; Deepak P Edward
Journal:  J Ophthalmol       Date:  2013-04-24       Impact factor: 1.909

Review 7.  Pediatric Glaucoma: A Literature's Review and Analysis of Surgical Results.

Authors:  Gianluca Scuderi; Daniela Iacovello; Federica Pranno; Pasquale Plateroti; Luca Scuderi
Journal:  Biomed Res Int       Date:  2015-09-16       Impact factor: 3.411

Review 8.  Wound Healing Modulation in Glaucoma Filtration Surgery-Conventional Practices and New Perspectives: The Role of Antifibrotic Agents (Part I).

Authors:  Jennifer C Fan Gaskin; Dan Q Nguyen; Ghee Soon Ang; Jeremy O'Connor; Jonathan G Crowston
Journal:  J Curr Glaucoma Pract       Date:  2014-06-12

9.  Decompression retinopathy following nonpenetrating deep sclerectomy for primary congenital glaucoma.

Authors:  Prithvi Ramtohul; Maëva Chardavoine; Marie Beylerian; Aurore Aziz; Frédéric Matonti; Danièle Denis
Journal:  BMC Ophthalmol       Date:  2018-09-05       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.